n/a
Article Publish Status: FREE
Abstract Title:

Naringenin has a chemoprotective effect in MDA-MB-231 breast cancer cells via inhibition of caspase-3 and -9 activities.

Abstract Source:

Oncol Lett. 2019 Jan ;17(1):1217-1222. Epub 2018 Nov 15. PMID: 30655887

Abstract Author(s):

Rui Wang, Junhai Wang, Tianfu Dong, Jun Shen, Xitao Gao, Jun Zhou

Article Affiliation:

Rui Wang

Abstract:

Breast cancer is the leading cause of cancer-associated mortality in females. It has an incidence of 1.3 million per year, which increases by 2% annually. In China, breast cancer accounts for 12.2% of all cancer cases. The aim of the present study was to investigate the inhibitory effect of naringenin on triple-negative breast cancer cells. Lactate dehydrogenase and MTT assay was used to investigate the inhibitory effect of naringenin on MDA-MB-231 cell viability. Naringenin reduced the viability of MDA-MB-231 cells by arresting the cell cycle at the Gphase. Naringenin treatment not only influenced the phase of cell cycle arrest, but also induced apoptosis in a dose-dependent manner. Naringenin treatment also resulted in a significant increase in caspase-3 and caspase-9 activity (P<0.001). Taken together, the results of the present study suggested that naringenin caused an inhibitory effect on MDA-MB-231 cells via induction of apoptosis and inhibition of caspase-3 and -9 activity.

Study Type : In Vitro Study

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.